APA (7th ed.) Citation

Goodlett, C. R., Stringer, M., LaCombe, J., Patel, R., Wallace, J. M., & Roper, R. J. (2020). Evaluation of the therapeutic potential of Epigallocatechin-3-gallate (EGCG) via oral gavage in young adult Down syndrome mice. Scientific Reports, 10(1), 1. https://doi.org/10.1038/s41598-020-67133-z

Chicago Style (17th ed.) Citation

Goodlett, Charles R., Megan Stringer, Jonathan LaCombe, Roshni Patel, Joseph M. Wallace, and Randall J. Roper. "Evaluation of the Therapeutic Potential of Epigallocatechin-3-gallate (EGCG) via Oral Gavage in Young Adult Down Syndrome Mice." Scientific Reports 10, no. 1 (2020): 1. https://doi.org/10.1038/s41598-020-67133-z.

MLA (9th ed.) Citation

Goodlett, Charles R., et al. "Evaluation of the Therapeutic Potential of Epigallocatechin-3-gallate (EGCG) via Oral Gavage in Young Adult Down Syndrome Mice." Scientific Reports, vol. 10, no. 1, 2020, p. 1, https://doi.org/10.1038/s41598-020-67133-z.